Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Gains from Investment Securities: 2024-2025

Historic Gains from Investment Securities for Camp4 Therapeutics (CAMP) over the last 2 years, with Sep 2025 value amounting to -$197,000.

  • Camp4 Therapeutics' Gains from Investment Securities fell 318.89% to -$197,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $189,000, marking a year-over-year change of. This contributed to the annual value of $364,000 for FY2024, which is 73.94% down from last year.
  • Camp4 Therapeutics' Gains from Investment Securities amounted to -$197,000 in Q3 2025, which was down 189.55% from $220,000 recorded in Q2 2025.
  • In the past 5 years, Camp4 Therapeutics' Gains from Investment Securities ranged from a high of $220,000 in Q2 2025 and a low of -$197,000 during Q3 2025.
  • For the 2-year period, Camp4 Therapeutics' Gains from Investment Securities averaged around $65,286, with its median value being $89,000 (2024).
  • Within the past 5 years, the most significant YoY rise in Camp4 Therapeutics' Gains from Investment Securities was 147.19% (2025), while the steepest drop was 318.89% (2025).
  • Over the past 2 years, Camp4 Therapeutics' Gains from Investment Securities (Quarterly) stood at $96,000 in 2024, then plummeted by 318.89% to -$197,000 in 2025.
  • Its Gains from Investment Securities was -$197,000 in Q3 2025, compared to $220,000 in Q2 2025 and $70,000 in Q1 2025.